Skip to main content
. 2017 Dec;9(12):5230–5238. doi: 10.21037/jtd.2017.11.109

Table 1. Baseline demographics and clinical characteristics.

Variable Sealant group (N=28) Control group (N=27) P value
Sex, n (%) 0.38
   Men 8 (28.6) 5 (18.5)
   Women 20 (71.4) 22 (81.5)
Age (years) 69.8±9.0 69.6±7.7 0.92
COPD, n (%)) 0.93
   No 20 (71.4) 19 (70.4)
   Yes 8 (28.6) 8 (29.6)
BMI >30, n (%) 0.16
   No 26 (92.9) 27 (100.0)
   Yes 2 (7.1) 0 (0)
Tobacco 20 smoking pack years, n (%) 0.89
   No 16 (57.1) 15 (55.6)
   Yes 12 (42.9) 12 (44.4)
Preoperative Chemotherapy, n (%) 0.32
   No 27 (96.4) 27 (100.0)
   Yes 1 (3.6) 0 (0)
Previous homo-lateral surgery, n (%) 0.32
   No 27 (96.4) 27 (100.0)
   Yes 1 (3.6) 0 (0)
FEV1 (L) 2.58±0.69 2.68±0.74 0.61
PaCO2 (mmHg) 38±3.9 38.4±3.12 0.71
PaO2 (mmHg) 81±9.1 83±7.5 0.60

Data were shown as number (percentage) or mean ± standard deviation. BMI, body mass index; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen.